ADHD medications fall into two main classes: stimulants and non-stimulants. Stimulants are the first-line treatment for most people and have the longest track record. Non-stimulants are typically tried when stimulants cause intolerable side effects or aren’t a good fit. Within those two classes, there are dozens of brand-name and generic options that differ in how long they last, how they’re taken, and how they work in the brain.
How Stimulants Work
Stimulant medications increase the availability of two chemical messengers in the brain: dopamine and norepinephrine. Both play a central role in attention, motivation, and impulse control. In ADHD, the brain clears these chemicals too quickly, which makes it harder to stay focused or regulate behavior. Stimulants slow that clearance, keeping dopamine and norepinephrine active longer in the spaces between nerve cells.
There are two stimulant families, and they achieve this effect differently. Methylphenidate-based drugs (like Ritalin and Concerta) block the transporters that pull dopamine and norepinephrine back into cells. Amphetamine-based drugs (like Adderall and Vyvanse) also block those transporters, but they go a step further by triggering additional dopamine release from nerve cells. This distinction matters because some people respond better to one family than the other, even though both are stimulants.
All stimulant ADHD medications are classified as Schedule II controlled substances by the DEA, meaning they carry a recognized potential for misuse and dependence. Prescriptions typically can’t be called in by phone and often require monthly check-ins.
Methylphenidate Medications
Methylphenidate comes in a wide range of formulations designed to cover different parts of the day. The short-acting versions, Ritalin and Focalin, last about 3 to 4 hours and are often used to cover specific windows like school hours or an evening study session. Because they wear off quickly, they sometimes need to be taken two or three times a day.
Extended-release options stretch coverage significantly. Concerta is one of the longest-acting, providing 8 to 12 hours of symptom control from a single morning dose. Ritalin LA and Metadate CD last roughly 6 to 8 hours. Aptensio XR and Focalin XR are capsules that can be opened and mixed with food, which is helpful for children who can’t swallow pills. Quillivant XR is a liquid, and Quillichew ER is a chewable tablet lasting up to 8 hours. Cotempla XR-ODT dissolves on the tongue without water.
A few newer options offer unique delivery methods. Daytrana is a skin patch that allows parents to physically remove the medication if side effects appear or coverage is no longer needed that day. Jornay PM is designed to be taken in the evening so it kicks in by the time you wake up. Azstarys, another extended-release option, is the only stimulant approved to be opened into water or applesauce. Relexxi is similar to Concerta but comes in three additional strength options not available with Concerta.
Amphetamine Medications
The amphetamine family includes its own range of short- and long-acting formulations. Short-acting options include Adderall, Evekeo, Zenzedi, Dexedrine, and ProCentra (a liquid form of Dexedrine). These generally last 4 to 6 hours.
Adderall XR extends that to 10 to 12 hours. Vyvanse, one of the most widely prescribed ADHD medications, lasts up to 14 hours but may take a bit longer to kick in each morning. It works differently from other amphetamines because the active ingredient is bound to an amino acid called lysine, which means the body has to process it before it becomes active. This built-in delay makes it harder to misuse and produces a smoother effect. Vyvanse is available as both a capsule and a chewable tablet.
Dexedrine Spansule is a long-acting form of Dexedrine lasting about 6 to 8 hours. Dyanavel XR, effective for 10 to 12 hours, comes in both liquid and chewable forms. Adzenys XR-ODT dissolves in the mouth. Mydayis is one of the longest-lasting options available, delivering medication in waves for up to 16 hours, which can be useful for adults who need late-afternoon or evening coverage. Xelstrym is an amphetamine skin patch worn for up to 9 hours.
FDA-Approved Non-Stimulants
The FDA has approved four non-stimulant medications for ADHD: Strattera (atomoxetine), Intuniv (guanfacine), Kapvay (clonidine), and Qelbree (viloxazine). None of these are controlled substances, which means prescriptions are generally easier to manage and there’s no recognized risk of chemical dependence.
Strattera was the first non-stimulant approved for ADHD. It works by blocking the reuptake of norepinephrine, keeping more of it available in the brain. Unlike stimulants, it doesn’t produce an immediate effect. Most people need several weeks of daily use before they notice the full benefit. This makes it a poor choice for as-needed use but a good option for people who want steady, all-day coverage without the peaks and valleys of stimulant dosing.
Qelbree, approved in 2021 for children aged 6 and older, works through a similar mechanism. It was originally developed as an antidepressant but showed clear benefits for ADHD symptoms. It has since gained approval for adults as well.
Intuniv and Kapvay work differently from the other two. They are extended-release versions of blood pressure medications (guanfacine and clonidine, respectively) that also improve attention and reduce impulsivity. Because they lower blood pressure, they require more careful monitoring when starting or stopping them. These are sometimes prescribed alongside a stimulant to address symptoms that the stimulant doesn’t fully control, particularly hyperactivity and emotional reactivity.
Off-Label Options
Some medications not specifically approved for ADHD are prescribed when standard options don’t work or aren’t appropriate. The most common is bupropion, sold as Wellbutrin. It affects both dopamine and norepinephrine and is typically considered when stimulant side effects are severe, when stimulants have been ineffective, or when a person also has depression or anxiety that could be treated with the same drug. Bupropion is also sometimes chosen when there’s concern about addiction risk with stimulants, since it doesn’t carry that potential. It’s not usually the first medication tried for ADHD. Doctors generally start with stimulants or approved non-stimulants like Strattera before turning to off-label alternatives.
Short-Acting vs. Long-Acting: Practical Differences
The choice between short-acting and long-acting medications shapes your daily routine more than almost any other treatment decision. Short-acting stimulants last 3 to 6 hours and offer flexibility. You can take them only on days you need them, or add an afternoon dose on long workdays. The trade-off is the “rebound effect,” a sharp drop in energy and mood as the medication wears off, sometimes accompanied by intense hunger and irritability.
Long-acting formulations (8 to 16 hours depending on the drug) are designed to carry you through most or all of the day on a single dose. They release medication gradually, which smooths out the peaks and crashes. For children in school, this often means not needing to visit the nurse’s office for a midday dose. For adults, it means more consistent focus through the workday and into the evening. The downside is less flexibility: if the medication suppresses your appetite or disrupts sleep, you can’t easily shorten its effects.
Common Side Effects Across Classes
The most frequently reported stimulant side effects are reduced appetite and weight loss. These tend to appear early in treatment and often improve after a few weeks as the body adjusts. Sleep disruption is another common issue, particularly with longer-acting formulations that are still active at bedtime. Some people experience increased heart rate or a slight rise in blood pressure, which is why periodic monitoring of blood pressure and pulse is standard practice, typically within 1 to 3 months of starting treatment and every 6 to 12 months after that.
Non-stimulants have their own side effect profiles. Strattera and Qelbree can cause nausea, fatigue, and mood changes, especially in the first few weeks. Intuniv and Kapvay tend to cause drowsiness and dizziness, partly because of their blood pressure-lowering effects. Blood pressure and heart rate need to be checked more frequently when these medications are being started or tapered.
Age Considerations
For young children between ages 4 and 6, behavioral interventions like parent training and classroom strategies are recommended as the first approach. Methylphenidate (Ritalin) may be introduced if behavioral methods alone aren’t enough, but it’s the only stimulant recommended at that age. From age 6 onward, the full range of FDA-approved stimulants and non-stimulants becomes available, and guidelines recommend combining medication with behavioral support for the best results. For adolescents, treatment decisions should involve the teen’s input and agreement. The same medication classes are used in adults, though formulation preferences may differ: adults often favor longer-acting options that cover a full workday, while patch or liquid forms are less commonly needed.